Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-04-05

Clinical Trial Update: Ultrasound-Guided 5% Dextrose Injection for Carpal Tunnel Syndrome [Phase 4]

View source ↗

Summary

Phase 4 clinical trial of ultrasound-guided 5% dextrose injection for carpal tunnel syndrome has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5% dextrose injection (ultrasound-guided) (dextrose 5% solution (ultrasound-guided injection))

Snippet

Sponsor: Kastamonu University | Conditions: Carpal Tunnel Syndrome | Phase 4 | Status: COMPLETED